Research Topics
| Douglas R AdkinsSummaryAffiliation: Washington University School of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Total body irradiation before an allogeneic stem cell transplantation: is there a magic dose?Douglas R Adkins
Division of Oncology, Siteman Cancer Center, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8007, St Louis, Missouri 63110, USA
Curr Opin Hematol 15:555-60. 2008..To review the outcomes of allogeneic transplantation with regimens of varying total body irradiation (TBI) doses (0-1575 cGy), with an emphasis on reduced-intensity conditioning (RIC) regimens...- Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamideChristopher L Hallemeier
Department of Internal Medicine, Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, St Louis, Missouri, USA
Biol Blood Marrow Transplant 12:749-57. 2006..In patients with MDS, this is an effective RIC regimen for allogeneic transplantation that can be used as an alternative to other RIC or conventional conditioning regimens... - Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphomaAmy L Hoerr
School of Medicine, Siteman Cancer Center, Washington University, St. Louis, MO, USA
J Clin Oncol 22:4561-6. 2004.... - Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factorsJason T Rich
Department of Otolaryngology Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri, USA
Laryngoscope 119:1709-19. 2009..Document survival, prognostic variables, and functional outcomes of patients with AJCC stage III or IV oropharyngeal cancer, treated with transoral laser microsurgery (TLM) +/- adjuvant therapy... - Recent advances in allogeneic hematopoietic stem-cell transplantationSteven M Devine
Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Department of Medicine, Siteman Cancer Center, Washington University School of Medicine
J Lab Clin Med 141:7-32. 2003 - Temporal relationship between antitumor necrosis factor-alpha antibody therapy and recrudescence of head and neck squamous cell carcinomaSamuel H Engel
Department of Otolaryngology Head and Neck Surgery, Washington University School of Medicine, St Louis, MO 63110, USA
Laryngoscope 118:450-2. 2008..The patient's clinical course illustrates a temporal relationship between reappearance of his cancer after a complete response to therapy and the resumption of infliximab for worsening Crohn's disease... - A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignanciesPaula M Fracasso
Department of Internal Medicine, Alvin J Siteman Cancer Center and Washington University School of Medicine, St Louis, MO, USA
Cancer Chemother Pharmacol 67:1225-37. 2011..We conducted a Phase I study to determine the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), pharmacokinetic, and pharmacodynamic effects of UCN-01 and irinotecan in patients with resistant solid tumors... - Squamous cell cancer of the head and neck with distant metastasis at presentationDavid I Kuperman
Division of Hematology Oncology, Department of Medicine, John Cochran Veterans Administration Medical Center, St Louis, Missouri, USA
Head Neck 33:714-8. 2011..We used the Surveillance Epidemiology and End Results (SEER) database to determine the rate of and risk factors for distant metastasis...